Diadema Partners »

Merck & Co shares owned by Diadema Partners

Quarter-by-quarter ownership of Merck & Co (MRK) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Merck & Co

Tip: Access up to 7 years of quarterly data

All positions including Merck & Co held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merck & Co by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $12M 100k 120.29

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Merck & Co

Vanguard Group
BlackRock
Vanguard Capital Management
State Street Corporation
Wellington Management Company
Vanguard Portfolio Management
Geode Capital Management
Charles Schwab Investment Management
Morgan Stanley
FMR
Bank of America Corporation
Northern Trust
Fisher Investments
Invesco
Goldman Sachs Group

View all funds holding Merck & Co